Introduction
Apoptosis (programmed cell death) is an innate cellular process in which the cells die in a controlled manner. In addition to its normal role in development and maintenance of adult tissues, apoptosis plays an important role in many aspects of tumorigenesis (Evan and Littlewood, 1998; Green and Martin, 1995) . Two families of proteins have been shown to play a major role in implementing and regulating apoptosis. The ®rst is a family of cysteine proteases, the caspases, which cleave substrates following aspartic residue and bring about cell death through proteolysis of proteins vital to cellular homeostasis (for reviews see Barinaga, 1998; Cohen, 1997; Nicholson and Thornberry, 1997; Salvesen and Dixit, 1997) . The second is the Bcl-2 family of proteins, which comprises both anti-and pro-apoptotic members and plays an important role in regulating caspase activation (for reviews see Chao and Korsmeyer, 1998; Farrow and Brown, 1996; Jacobson, 1997) . The anti-apoptotic members of the Bcl-2 family include Bcl-2, Bcl-x L , Bcl-W, Mcl-1, B¯1/ A1, E1B 19k, Epstein-Barr virus BHRF1, and Caenorhabditis elegans Ced-9. Pro-apoptotic members include Bax, Bak, Bad, Bik, Bid, Bim, Hrk, Bok/Mtd, Blk and Bcl-x S (for review see Hegde et al., 1998; Hsu et al., 1997; Kelekar and Thompson, 1998; O'Connor et al., 1998; Strasser et al., 1997 and references therein) . The homology between members of the Bcl-2 family resides mainly within four conserved domains, designated Bcl-2 homology (BH) domains BH1, BH2, BH3 and BH4. All four BH domains are present in some Bcl-2 family members, such as Bcl-2 and Bcl-x L . Others (Bax, Bak and Bok) contain the BH1, BH2 and BH3 domains and lack BH4, while yet others (Bik, Hrk, Bim and Bid) contain only the BH3 domain. The mechanism(s) underlying the activities of these anti-and proapoptotic proteins are not completely understood. It is clear, however, that they are multifunctional proteins which may exert dierent actions in dierent systems (for review see Kelekar and Thompson, 1998 ).
An important feature of the Bcl-2 family members is that they are capable of dimerizing with themselves or with other members of the family. It was proposed that the pro-apoptotic proteins promote cell death by dimerizing with anti-apoptotic proteins and that the susceptibility of a cell to apoptotic signals is regulated by the ratio of anti-to proapoptotic proteins . However, observations suggest that at least some members of the Bcl-2 family might also work independently of one another (see, e.g., Cheng et al., 1996) . In addition, it was proposed that as a result of apoptotic stimuli, some pro-apoptotic proteins of the Bcl-2 family, e.g., Bax, Bad and Bid, translocate to the mitochondria, where they induce mitochondrial damage which in turn results in the execution of apoptosis (for reviews see Li and Yuan, 1999) . It is unclear, however, whether other pro-apoptotic members of the family have the same mechanism of action.
The bcl-x gene has three alternative splice forms, bcl-x L(a) , bcl-x (b) and bcl-x S(g) (Boise et al., 1993; GonzaÂ lez-GarcõÂ a et al., 1994) . The bcl-x L gene encodes a 233-amino-acid protein containing the four BH domains and a transmembrane region, Bcl-x S ; however, as a result of alternative splicing, lacks an internal 63-amino-acid segment that contains the conserved BH1 and BH2 domains. It therefore contains only the BH3 and BH4 domains and the transmembrane region. Previous studies have shown that Bcl-x S is a pro-apoptotic protein which in stable transfectants inhibits the ability of Bcl-2 or Bcl-x L to protect the cells from apoptosis induced by dierent stimuli (Boise et al., 1993; Minn et al., 1996) .
Although Bcl-x S was one of the ®rst pro-apoptotic proteins to be isolated, little is known about its mechanism of action and its role in physiological cell death. However, the ®nding that Bcl-x S mRNA levels are increased in some apoptotic systems, e.g. transient forebrain global ischemia (Dixon et al., 1997) , apoptosis in involuting mammary epithelial cells (Heermeier et al., 1996) and in injured carotid artery (Igase et al., 1999) , suggests that Bcl-x S may participate in the apoptotic pathway in these systems.
Furthermore, transient expression of Bcl-x S by infection with adenovirus vector containing bcl-x S cDNA was found to induce apoptosis in various cancer cells, suggesting that targeting of Bcl-x S expression into cancer cells may be a useful therapeutic approach of killing these cells (Clarke et al., 1995; Ealovega, 1996; Dole et al., 1996) .
It is now well established that apoptotic pathways may vary between dierent cell types, and that the particular pathway employed depends on the cell type. In an attempt to gain a better understanding of the molecular mechanism underlying the proapoptotic action of Bcl-x S in cancer cells and to compare it to that of Bax, we examined the eects of Bcl-x S and Bax in the rat pheochromocytoma line PC12, a well characterized cellular model system commonly used for the study of neuronal apoptosis (see, e.g., Haviv et al., 1998; Pittman et al., 1993; Stefanis et al., 1996) . Our results suggest that Bcl-x S and Bax dier in their apoptotic eects in PC12 cells. Bcl-x S -induced apoptosis requires caspase activity and is inhibited by nerve growth factor (NGF) whereas Bax-induced cell death is independent of caspases and is not inhibited by NGF. Both the Bcl-x S -induced and the Bax-induced apoptotic pathways were inhibited by co-expression with Bcl-2; however, Bcl-2 mutants which did not protect PC12 cells against Bax-induced cell death partially protected these cells against cell death induced by Bclx S . These results further suggest that Bcl-2 can inhibit the Bax-induced, caspase-independent pathway by a mechanism that diers from the one that inhibits Bcl-x S -induced apoptosis.
Results
Differential distribution of Bcl-x L , Bcl-x S and Bax proteins upon subcellular fractionation PC12 cells have been shown to express both Bax and Bcl-x L (Maroto and Perez-Polo, 1997) . In order to determine the suitability of PC12 cells as a cellular model system for studying the mechanism of action of Bcl-x S , we inspected these cells for Bcl-x S expression. Western blot analyses, using polyclonal anti Bcl-x antiserum that recognizes both Bcl-x S and Bcl-x L , showed that PC12 cells express both Bcl-x proteins, Bcl-x S (MW about 18 kDa), and ± predominantly ± Bcl-x L (MW about 29 ± 31 kDa) (Figure 1a) . In attempting to understand and compare the mechanisms of action of Bcl-x S and Bax, it is necessary to determine their subcellular localization. Moreover, because Bcl-x S and Bcl-x L share identical amino acid sequences (except for the absence of 63 internal amino acids in Bcl-x S ) which include the transmembrane region, and as Bcl-x S was shown to be capable of antagonizing the protective eect of Bcl-x L (Minn et al., 1996) , it is important to know whether these two Figure 1 Expression and subcellular distribution of Bcl-x S , Bclx L and Bax in PC12 cells. (A) Expression of Bcl-x L and Bcl-x S proteins in PC12 cells. Cell lysates were separated by 12.5% SDS ± PAGE, and this was followed by Western blotting using anti-Bcl-x antibody as a probe. (B) Localization of Bax and Bcl-x proteins by subcellular fractionation. Cells were lysed and subcellular fractionation was performed as described in Materials and methods. Equivalent proportions of each fraction [heavy membranes (HM), light membranes (LM) and cytosol] were subjected to SDS ± PAGE (12.5%) immunoblot analysis using antibodies speci®c for Bcl-x, Bax, cytochrome oxidase (Cyto Oxidase), cytochrome c (Cyto c) porin and calnexin proteins are located in the same subcellular compartments. PC12 cells were therefore subjected to fractionation by dierential centrifugation and the expression of Bcl-x L , Bcl-x S and Bax proteins in each subcellular fraction was monitored by Western blotting.
As shown in Figure 1b , most if not all of the Bcl-x S proteins were found in the cytosolic fraction, whereas Bcl-x L and Bax proteins were present in the heavy and light membrane fractions in addition to the cytosol. Bcl-x L proteins were prominent in the heavy and light membrane fractions and Bax proteins in the cytosolic and heavy membrane fractions. The predominant presence of the outer mitochondrial membrane protein, porin, or the inner mitochondrial membrane protein, cytochrome oxidase subunit IV, as well as of cytochrome c (which normally resides in intermembrane spaces), in the heavy membrane fraction suggested that the mitochondria are highly enriched in this fraction and that both inner and outer mitochondrial membranes are largely intact. The presence of the endoplasmic reticulum (ER) protein, calnexin, in the heavy membrane fraction suggests that this fraction contains ER proteins. Taken together, these results suggested that in PC12 cells the two proapoptotic proteins Bax and Bcl-x S dier in their subcellular distribution. Interestingly the Bcl-x proteins also dier in their subcellular distribution, i.e., Bcl-x L is prominently in the heavy membrane fraction, probably in the outer mitochondrial membrane (GonzaÂ lezGarcõÂ a et al., 1994), whereas Bcl-x S does not reside in the mitochondria but in the cytosol.
Transient overexpression of Bcl-x S or Bax induces apoptosis in PC12 cells
The eects of Bcl-x S and Bax on PC12 cells were examined by transient transfection with Bcl-x S or Bax expression vectors that promote the expression of exogenous Bcl-x S or Bax mRNAs in the transfected cells, as revealed by RT ± PCR analysis employing PCR primers designed to speci®cally amplify cDNA sequences derived from the exogenous but not the endogenous Bcl-x S or Bax mRNA (Figures 2c and 3c  respectively) .
Following transient cotransfection of Bcl-x S or Bax expression vectors with either green¯uorescent protein (GFP) or secreted alkaline phosphatase (SEAP) reporter gene, the eect of Bcl-x S or Bax overexpression on the viability of PC12 cells was examined by monitoring the number of GFP-positive cells or SEAP Bcl-x S and Bax cytotoxicity is countered by Bcl-2 and Bcl-x L To gain further insight into the relationship between Bcl-x S or Bax and the anti-apoptotic molecules Bcl-2 and Bcl-x L , we examined whether these anti-apoptotic molecules inhibit Bcl-x S -or Bax-induced cell death in transiently transfected PC12 cells. PC12 cells were cotransfected with Bcl-x S and SEAP or with Bax and SEAP and either Bcl-x L or Bcl-2 expression vectors, and the viability of the transfected cells was measured by the SEAP activity assay. As shown in Figure 4 , both Bcl-x L and Bcl-2 countered the cell death induced by Bax or Bcl-x S .
Effect of Bcl-2 mutants on Bcl-x S -and Bax-induced cell death
Mutations within the BH1 domain of Bcl-2 [G145A(mI-3) and G145E (mI-4)] have been shown to eliminate the Bcl-2 death repressor activity in several apoptotic systems, and to disrupt Bcl-2 heterodimerization with Bax (Yin et al., 1994) . The Bcl-2DC22 mutant, on the other hand, reportedly provides partial protection from cell death and is capable of interacting with Bax (Oltvai et al., 1993) . In an attempt to further our understanding of the interaction between Bcl-2 and Bcl-x S , as well as to compare the apoptotic pathways induced by Bcl-x S and by Bax, we examined the eects of the Bcl-2 mutants mI-3, mI-4 and DC22 on Baxinduced and Bcl-x S -induced cell death. As shown in Figure 5 , Bax-induced death of PC12 cells was not prevented by co-expression of any of the three tested Bcl-2 mutants. However, co-expression of mI-3 or DC22 (but not mI-4) Bcl-2 mutants with Bcl-x S substantially protected the cells against death induced and untransfected PC12 cells (lane 2) were subjected to RT ± PCR analysis. PCR primers that¯ank the 5' and 3' ends of the exogenous Bax mRNA were used to amplify speci®cally exogenous Bax mRNA, as described in Materials and methods. Lane 3 shows the PCR product obtained from pcDNA3HAmu-Bax using the same primers by Bcl-x S . These results showed that the mI-3 and DC22 mutations do not eliminate the anti-apoptotic eect of Bcl-2 on Bcl-x S -induced cell death. Taken together, the eects of the Bcl-2 mutants on Bcl-x Sinduced and Bax-induced cell death suggested that the apoptotic pathway induced by transient transfection of Bcl-x S may dier from that induced by Bax and that the mechanisms whereby Bcl-2 inhibits these pathways may also dier.
Bcl-x S -induced but not Bax-induced cell death requires the activity of caspases Caspases play an essential role in apoptosis induced by various stimuli. In an attempt to ®nd out whether the activity of caspases is needed for cell death induced by Bcl-x S or Bax in PC12 cells, we examined the eect of the broad-spectrum caspase inhibitor, Z-VAD-FMK (100 mM), on the viability of PC12 cells transiently transfected with Bcl-x S or Bax. As shown in Figure 6 , the addition of Z-VAD-FMK completely abolished the Bclx S -induced cell death (Figure 6a ) but had no protective eect on Bax-induced cell death (Figure 6b ). Z-DEVD-FMK (100 mM) (caspase-3-like inhibitor) also did not have a protective eect on Bax-induced cell death (Figure 6b ). These results suggest that caspase activity is needed for death induction by Bcl-x S but not by Bax, and further support the notion that the pathways of cell death induced by Bcl-x S and by Bax may dier.
Next we attempted to ®nd out which caspases are required for the Bcl-x S eect. The involvement of caspase-1-like and caspase-3-like proteases was examined by determining the eects of their speci®c peptide inhibitors, Ac-YVAD-CHO, Ac-YVAD-CMK (caspase-1-like inhibitors) and Ac-DEVD-CHO (caspase-3-like inhibitor), on the viability of Bcl-x S -transfected PC12 cells. As shown in Figure 6a , none of these inhibitors, at concentrations consistent with their speci®c eects (200 mM for Ac-YVAD-CHO and Ac-YVAD-CMK and 300 or 600 mM for Ac-DEVD-CHO) had any protective eect against Bcl-x S -induced cell death. Similar results were obtained when 200 mM Ac-YVAD-CHO and 300 mM Ac-DEVD-CHO were added together to Bcl-x S -transfected PC12 cells (data not shown). These results thus suggest that caspase-1-like and caspase-3-like proteases are not the caspases which are needed for the Bcl-x S death eect.
NGF inhibits Bcl-x S but not Bax-induced cell death
Previous studies have shown that NGF can inhibit apoptosis induced by various stimuli via pathways that may involve inhibition of caspases (Stefanis et al., 1998) . In order to further characterize the mechanism whereby Bcl-x S and Bax induce cell death and to relate it to the survival pathway of NGF we attempted to determine whether NGF would inhibit the death induced by Bcl-x S or Bax expression in PC12 cells. PC12 cells were transiently cotransfected with SEAP and either Bcl-x S or Bax in the presence and in the absence of NGF (50 ng/ml). As shown in Figure 7 , addition of NGF to Bcl-x S -transfected cells substan- tially inhibited the death-inducing eect of Bcl-x S but not of Bax. These results suggest that the survival pathway of NGF can aect the Bcl-x S -induced but not the Bax-induced death pathway.
Careful inspection of the morphology of PC12 cells cotransfected with Bcl-x S and the GFP reporter gene and treated with NGF, reveals that most of the GFPpositive cells exhibited membrane blebbing (Figure 8 ). This morphology, which is a characteristic feature of apoptotic cells in the early phase, was also exhibited by GFP-positive cells in Bcl-x S -transfected cultures treated with the caspase inhibitor, Z-VAD-FMK (Figure 8) . These results thus suggest that NGF aects the Bcl-x Sinduced cell death pathway at a stage of apoptosis similar to that aected by Z-VAD-FMK, i.e., caspase activity.
Subcellular distribution of transfected Bcl-x S in PC12 cells
The results presented in Figure 1 show that endogenous Bcl-x S in living cells is cytosolic. To further characterize the apoptotic eect of the overexpressed Bcl-x S , PC12 cells were transiently transfected with an expression vector that directs the expression of Bcl-x S tagged with a FLAG epitope. The subcellular localization of the exogenously expressed FLAG-tagged Bcl-x S protein was determined by staining the cells with anti-FLAG antibody. As shown in Figure 9 , immuno¯uorescence analysis of confocal microscopy revealed that FLAGtagged Bcl-x S had a punctuated immunoreactivity consistent with an association with intracellular membrane. Cells were double-stained with MitoTracker Red, a mitochondria speci®c dye and FLAG-tagged Bcl-x S and their dual exposure revealed that most FLAGtagged Bcl-x S proteins are localized in the mitochondria.
Discussion
The Bcl-2 family of proteins includes both antiapoptotic and pro-apoptotic members. Increasing evidence suggests that some pro-apoptotic members act and are regulated by multiple mechanisms and that a particular member may exert opposite eects in dierent cell types (Middleton et al., 1996; Song et al., 1999) . Therefore, in order to understand the apoptotic mechanism of action of this family of proteins, it is important to study and compare the mechanisms of action of dierent family members. One such protein, Bcl-x S , has been implicated in apoptosis induced by various stimuli in several tissues and cancer cells (see, e.g., Clarke et al., 1995) . In the present study we therefore investigated the mechanism of action of Bcl-x S in apoptosis of PC12 cells (a cancer cell line commonly used for the study of neuronal apoptosis) and compared it to that of Bax. We showed that in PC12 cells, endogenous Bax is present mainly in the cytosolic and the heavy membrane fractions whereas Bcl-x S protein is located entirely in the cytosolic subcellular fraction. Overexpression of Bcl-x S in PC12 cells induces apoptosis and translocation of Bcl-x S protein to the mitochondria. The apoptotic eect of Bcl-x S required caspase activity and was inhibited by the anti-apoptotic members of the Bcl-2 family, Bcl-2 and Bcl-x L , as well as by the survival factor NGF. Transient overexpression of Bax, however, induced a caspase-independent cell death pathway which was blocked by Bcl-2 but not by the NGF signaling pathway. These results thus suggest that Bcl-x S and Bax induce dierent cell death pathways in PC12 cells. Figure 9 Subcellular distribution of exogenous Bcl-x S proteins in PC12 cells. PC12 cells transiently transfected with FLAG-tagged Bcl-x S were cultured with 250 nM MitoTracker Red, ®xed, permeabilized and incubated with monoclonal mouse anti-FLAG antibody followed by¯uorescein isothiocyanate-conjugated secondary antibody. Cells were imaged by two-color confocal immunouorescence microscopy (magni®cation64800). Colocalization of Bcl-x S with the mitochondria is revealed by overlaying of the images Figure 7 NGF inhibits Bcl-x S -induced but not Bax-induced cell death. PC12 cells were cotransfected for 24 h with pcDNA3 and SEAP or Bcl-x S and SEAP or Bax and SEAP expression vectors in the presence or absence of NGF (50 ng/ml). Cell survival is de®ned as described in Figure 6 . Data are expressed as means+s.d. values (bars) (n=3) Figure 8 Morphology of GFP-positive cells in Bcl-x S -transfected cultures treated with NGF or Z-VAD-FMK. PC12 cells were cotransfected for 24 h with pcDNA3 and GFP or Bcl-x S and GFP expression vectors and treated with either 50 ng/ml NGF or 100 mM Z-VAD-FMK. Photographs (magni®cation61200) were taken using a standard¯uorescein isothiocyanate ®lter set Differential distribution of endogenous Bcl-x S , Bax and Bcl-x L proteins in PC12 cells upon subcellular fractionation Our ®ndings suggest that endogenous Bcl-x S , Bax and Bcl-x L have dierent subcellular localizations. Most or all of the Bcl-x S protein was present in the cytosolic fraction. Bax protein was prominent in the cytosol and the heavy membrane fractions, whereas Bcl-x L was prominent in the heavy and light membrane fractions. Extensive homogenization during cell fractionation may lead to the disruption of the mitochondrial outer membrane, which may lead in turn to contamination of the cytosolic fraction by proteins located in the intermembrane space of the mitochondria or by proteins that are weakly associated with the outer mitochondrial membrane. This is unlikely to account for the presence of Bcl-x S in the cytosolic fraction, since the outer mitochondrial membrane protein porin and the mitochondrial intermembrane protein cytochrome c were present predominantly in the heavy membrane fraction, indicating that the outer mitochondrial membranes were largely intact. The predominant presence of endogenous Bcl-x S in the cytosolic fraction in our study is in agreement with previous studies showing its cytosolic distribution in CEM cells (Jia et al., 1999) .
Translocation of exogenously expressed Bcl-x S to the mitochondria
Our results show that in PC12 cells, endogenous Bcl-x S is localized in the cytosol. Following overexpression of Bcl-x S , the transfected cells die and the exogenous Bclx S is presented in the mitochondria. These results therefore suggest that, as shown previously for other pro-apoptotic members of the family [such as Bax and Bid (Goping et al., 1998; Li et al., 1998) ], translocation of Bcl-x S to the mitochondria is important for the Bclx S -induced death eect. It is not known why overexpression of Bcl-x S resulted in its translocation to the mitochondria. One possible mechanism is that Bcl-x S is maintained in the cytosol via interaction with a limited amount factor and thus the excess of Bcl-x S can be released from the constraint of this factor and translocated to the mitochondria. Alternatively, Bcl-x S may posses two conformations, one of which is favored under unapoptotic conditions and does not allow it to integrate to the mitochondria, and a second which allows it to integrate. Upon overexpression, few Bcl-x S molecules spontaneously change their conformation and acquire the conformation which would enable them to integrate to the mitochondria. This in turn may induce an ampli®cation loop which leads to conformational changes in the remainder of Bcl-x S molecules expressed in the cells. Further studies are needed to unravel the mechanism of Bcl-x S translocation to the mitochondria. Our ®nding of the mitochondrial localization of exogenous Bcl-x S in PC12 cells is in agreement with that which previously showed intracellular membranous distribution of exogenous Bcl-x S in FL5.12 cells (Minn et al., 1996) .
Overexpression of Bcl-x S induces apoptosis in PC12 cells
Transient cotransfection of Bcl-x S with the reporter gene GFP or SEAP in PC12 cells induced a rapid reduction in the number of GFP-positive cells or in SEAP activity in Bcl-x S transfected cells compared to cells transfected with control empty vector. The diminution most probably represents Bcl-x S -induced apoptosis, as studies from other laboratories as well as ours have established that the expression of reporter genes is eliminated in cells undergoing apoptosis ( Figure 3B and see, e.g., Wang et al., 1996) . The ability of the anti-apoptotic proteins Bcl-2 and Bcl-x L to inhibit the Bcl-x S eect, and the need of the latter for caspase activity, further support the notion that overexpression of Bcl-x S induces apoptosis in transfected PC12 cells. Furthermore, inhibition of Bcl-x Sinduced cell death by NGF or by the caspase inhibitor Z-VAD-FMK resulted in the appearance of a cell morphology characteristic of apoptotic cells in which the apoptotic process was attenuated by inhibition of caspase activity (McCarthy et al., 1997) .
Effect of Bcl-2 mutants on Bcl-x S -induced cell death
Our results show that apoptosis induced by overexpression of Bcl-x S can be antagonized by Bcl-2. In an attempt to elucidate the relationship between the proapoptotic and the anti-apoptotic functions of Bcl-x S and Bcl-2, we examined the ability of the mI-3, mI-4 and DC22 Bcl-2 mutants to inhibit Bcl-x S -induced cell death. The results showed that the mI-3 and the DC22 mutants are eective in this regard. It was previously shown that the mI-3 mutation causes Bcl-2 to lose its capacity for heterodimerization with Bax (St. Clair et al., 1997; Yin et al., 1994) and Bid (Wang et al., 1996) . The ability of the mI-3 Bcl-2 mutant to inhibit Bcl-x Sinduced cell death thus demonstrates that this mutation does not eliminate the anti-apoptotic eect of Bcl-2, at least with respect to apoptosis induced by Bcl-x S .
Bcl-x S -induced cell death requires caspase activity
The death of Bcl-x S transfected PC12 cells was completely prevented by the addition of Z-VAD-FMK, a broad-spectrum inhibitor of caspases, suggesting that caspase activity is required for apoptosis induced by Bcl-x S . The need for caspase activity was also reported in the induction of apoptosis by transient overexpression of some other anti-apoptotic members of the Bcl-2 family of proteins, for example Bid (Wang et al., 1996) , Bak and Bik (Orth and Dixit, 1997) and Bok (Hsu et al., 1997) .
The speci®c caspases participating in Bcl-x S -induced apoptosis have yet to be identi®ed. From our results, it seems that caspase-1-like and caspase-3-like proteases are not required for this death process, as their speci®c peptide inhibitors [Ac-YVAD-CHO and Ac-YVAD-CMK for caspase-1-like proteases and Ac-DEVD-CHO or Z-DEVD-FMK (100 mM) (data not shown) for caspase-3-like proteases] did not inhibit the Bcl-x Sinduced cell death.
NGF inhibits the Bcl-x S -induced apoptosis
The results of this study showed that NGF inhibits the Bcl-x S -induced apoptosis in PC12 cells. The mechanism whereby NGF inhibits this process is not yet known. NGF inhibits apoptosis induced by various treatments (Lindenboim et al., 1995; Rukenstein et al., 1991; Spear et al., 1997) , but its survival eect in these apoptotic systems is not fully understood. Recent studies suggest that the eects of NGF and other survival factors are mediated via the activation of phosphatidylinositol-3-kinase and its downstream target, the serine-threonine kinase Akt/PKB (Crowder and Freeman, 1998; Hemmings, 1997; Spear et al., 1997; Yao and Cooper, 1995) , which in turn phosphorylates BAD, an antiapoptotic member of the Bcl-2 family (Datta et al., 1997) . NGF was also shown to induce Bcl-2 phosphorylation (Horiuchi et al., 1997) and expression (Katoh et al., 1996) . Taken together, these results are in accordance with our ®ndings and suggest that at least some of the NGF survival signals converge to modulate the function of the Bcl-2 family of proteins, which in turn regulate caspase activation. Alternatively, NGF may lead to direct inhibition of the activity of caspases by inducing their phosphorylation, as shown for Akt/PKB-mediated phosphorylation of pro-caspase-9 (Cardone et al., 1998) . The possibility that NGF acts on Bcl-x S signaling at the level of caspase inhibition is supported by our ®ndings showing that the morphology of Bcl-x S -transfected cells treated with NGF is similar to that of Bcl-x S -transfected cells treated with the caspase inhibitor Z-VAD-FMK. The ®nding that NGF can inhibit the apoptotic eect of Bcl-x S is in accordance with the observation of Martinou et al. (1995) , who showed that injection of Bcl-x S into sympathetic neurons grown in the presence of NGF had no eect on the neurons' viability.
Bax and Bcl-x S induce different cell death pathways in PC12 cells
Overexpression of Bax in PC12 cells also induces cell death, as indicated by the reduction in the number of GFP-positive cells or in SEAP activity in Baxtransfected cells compared to cells transfected with control empty vector, and by the inhibition of these processes by Bcl-2 or Bcl-x L . The Bax-induced cell death pathways dier, however, from that of Bcl-x S in PC12 cells. Accordingly, Bax-induced cell death is caspase-independent and is not aected by the NGF signaling pathway, since caspase inhibitors as well as NGF failed to inhibit it. Furthermore, in contrast to the protective eect of mI-3 and DC22 against Bcl-x Sinduced cell death, these Bcl-2 mutants were not eective in protecting the cells against Bax-induced cell death. Our ®ndings in connection with the Bcl-2 mutant mI-3 are in agreement with those of St. Clair et al. (1997) showing that in the T-cell lineage, Bcl-2 mI-3 protects immature CD4+8+ thymocytes but not peripheral T-cells from apoptosis. Taken together, the above ®ndings suggest that these two pro-apoptotic members of the Bcl-2 family, Bcl-x S and Bax, induce cell death via dierent routes in the same cell. The Bcl-x S pathway is mediated by caspases and is inhibited by NGF, probably at the level of caspase activity, whereas the Bax pathway does not require caspase activity.
Bcl-2 inhibits both Bcl-x S -induced and Bax-induced cell death. However, the mechanisms whereby Bcl-2 exerts its protective eect on these processes may dier. This possibility is supported by the ®ndings that the mI-3 and DC22 Bcl-2 mutants had a dierential eect on these two pathways.
The ®nding that Bcl-2 and Bcl-x L can inhibit Baxinduced cell death further suggests that these two antiapoptotic proteins can inhibit caspase-independent cell pathways, and is in agreement with previous studies showing that apoptosis induced by a defect in the ubiquitin pathway or by nitric oxide are mediated by a caspase-independent pathway which is blocked by Bcl-2 (Okuno et al., 1998; Monney et al., 1998) . The ®nding that Bax induces caspase-independent cell death is in agreement with previous reports (Xiang et al., 1996; Pastorino et al., 1998; Gross et al., 1998) , although other studies show that the Bax-induced cell death requires caspase activity (Pan et al., 1998; Martinou et al., 1998; Finucane et al., 1999; Cheng et al., 1997) . This discrepancy may be attributable to the fact that Bax can induce both caspase-dependent and caspase-independent pathways and that the pathway employed may depend on the nature of the cells which express it. Our results suggest, however, that the factor(s) determining which of these pathways will be used by Bax do not aect Bcl-x S in the same way, since Bcl-x S in the same cells induces caspase-dependent cell death.
Materials and methods

Reagents
NGF was purchased from Chemicon International (Harrow, UK). N-acetyl-Tyr-Val-Ala-Asp-chloromethylketone (Ac-YVAD-CMK) and N-acetyl-Tyr-Val-Ala-Asp-aldehyde (Ac-YVAD-CHO) were purchased from Calbiochem (San Diego, CA, USA), benzyloxycarbonyl-Val-Ala-Asp-¯uoro-methylketone (Z-VAD-FMK) and benzyloxycarbonyl-Asp-Glu-ValAsp-¯uoro-methylketone (Z-DEVD-FMK) were from Enzyme Systems (Dublin, CA, USA), and N-acetyl-Asp-GluVal-Asp-aldehyde (Ac-DEVD-CHO) was from Biomol Research Laboratories (Plymouth Meeting, PA, USA). Z-VAD-FMK, Z-DEVD-FMK and Ac-DEVD-CHO were resuspended as 50-mM stock solutions in dimethylsulfoxide (Merck Darmstadt, Germany) and Ac-YVAD-CMK was resuspended as a 10-mM stock solution in dimethylsulfoxide. Ac-YVAD-CHO was resuspended as a 100-mM stock solution in water. Lipofectamine was purchased from Gibco-BRL (Life Technologies, Renfrewshire, Scotland). MitoTracker Red CMXRos was purchased from Molecular Probes, Inc. (Oregon, USA) and was resuspended as 1-mM stock solutions in dimethylsulfoxide. All other reagents were purchased from Sigma (St. Louis, MO, USA), unless otherwise stated.
Cell culture PC12 cells were grown in high-glucose Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with heat-inactivated horse serum (8%) and fetal calf serum (FCS) (8%).
Plasmids
A Bcl-x S -FLAG construct was generated by inserting in frame the EcoRV/XhoI Bcl-x S cDNA fragment, which was generated using RCR on pBluescript SK(+)Bcl-x S using the 5' primer 5'-GTCAGATATCTTCTCAGAGCAACCGG-3' and the 3' primer 5'-GTCACTCGAGTGGTCACTTCC-GACT-3' into the EcoRV/XhoI sites of a derivative of the pcDNA3 mammalian expression vector that incorporates an N-terminal FLAG (MDYKDDDDK)-tag. Human Bcl-x S and Bcl-x L expression vectors were generated by subcloning the 600-bp and 800-bp EcoRI fragments from pBluescript SK(+)bcl-x S and pBluescript SK(+)bcl-x L , respectively (Boise et al., 1993) , into the EcoRI site of pcCDNA3. pEGFP-3 (Clontech) encodes a red-shifted variant of wildtype green¯uorescence protein (GFP) under the control of cytomegalovirus (CMV) promoter. pCMV ± SEAP was obtained from Dr Pradier (Rhone-Poulenc Rorer). The vectors pcDNA3Bcl-2, pcDNA3Bcl-2 mI-3 (G145A), pcDNA3Bcl-2 mI-4 (G145E) and pcDNA3Bcl-2DC22 (with deletion of 22 amino acids from the C-terminal, which contains the signal anchor sequence) were generated by inserting cDNAs of human wild-type Bcl-2 (Seto et al., 1998) and its mutant cDNAs (Oltvai et al., 1993; Yin et al., 1994) into the EcoRI site of pcDNA3. The Bax expression vector pcDNA3HA muBax contains mouse Bax cDNA (Oltvai et al., 1993) and was generated in Dr Korsmeyer's laboratory (Washington University, St. Louis, MO, USA).
Transfection
One day before transfection, PC12 cells were seeded at a density of 2610 5 cells/well in 24-well plates. To each well, 300 ml of DNA-lipofectamine mixture [2 mg of DNA and 30 mg of lipofectamine in 1 ml of OPTI-MEM (Gibco-BRL)] were added according to the manufacturer's instructions. Each transfection was performed in triplicate. Following incubation of cells for 5 h with the DNA lipofectamine mixture, 300 ml of DMEM supplemented with 16% serum was added and incubation was continued. For the experiments aimed at examining the eects of dierent factors (e.g., growth factors and caspase inhibitors) on the Bax-induced or Bcl-x S -induced cell death, the factors were added to the culture medium 5 h after the addition of the DNA ± lipofectamine mixture. The viability of the transfected cells in all experiments was monitored, 24 h after transfection, by measuring both the activity of SEAP in the medium of the transfected cells and by counting GFP-positive cells visualized by¯uorescent microscopy.
The ratios of the dierent DNA species in each transfection were as follows: 1 : 1 : 1 for Bcl-x S or Bax/Bcl-2, Bcl-x L , or Bcl-2 mutant/reporter plasmid (SEAP or GFP). In the experiments with caspase inhibitors or NGF, the ratio of Bax plasmids/reporter plasmid was 2 : 1 and the ratio of Bclx S plasmids/reporter plasmid/pcDNA3 was 3 : 2 : 1. Under these conditions dierent DNA species are taken up by the same cells, as demonstrated by cotransfection of PC12 cells with both GFP and blue¯uorescent protein (BFP) expression vectors (CLONTECH, Palo Alto, CA, USA). More than 90% of the cells were both GFP-and BFP-positive (data not shown).
RNA isolation and reverse transcription (RT ± PCR) analysis
Total RNA was extracted from PC12 cells by the method of Chomczynski and Sacchi (1987) . DNase-I-treated RNA (2 ± 5 mg) from PC12 cells was used for RT, employing either the endogenous bcl-x 3' primer 5'-GTA GAG TGG ATG GTC AGT G-3' or the exogenous pcDNA3Bcl-x S and pcDNA3-HAmuBax 3' primer 5'-GTG ACA CTA TAG AAT AGG GC-3' and the Titan TM RT ± PCR system (Boehringer, Mannheim).
To amplify endogenous Bcl-x L and Bcl-x S and exogenous pcDNABcl-x S cDNAs, we used the 5' primer 5'-TTG GA-C AAT GGA CTG GTT GA-3' together with the 3' primers 5'-GTA GAG TGG ATG GTC AGT G-3' for Bcl-x L and Bcl-x S cDNAs or 5'-GTG ACA CTA TAG AAT AGG GC-3' for pcDNABcl-x S cDNA. To amplify exogenous Bax cDNA we used the 5' primer 5'-GAT CCA TGA GAA TTC TAG ATG GAC GGG TCC-3' together with the 3' primer 5'-GTG ACA CTA TAG AAT AGG GC-3'. The following conditions were chosen for the PCR reactions: 16 reaction buer (Appligene, Pleasanton, CA, USA), 50 mM dNTP, each primer at 1 mM, 0.5 U Taq DNA polymerase (Appligene) at a total volume of 50 ml. DNA was ampli®ed in 30 cycles of 948C for 1 min, 588C for 1 min and 728C for 3 min. In the case of Bax, after 30 cycles, 2 ml of the PCR product were used for a second round of ampli®cation to increase its amount.
Subcellular fractionation, immunoblotting and immunofluorescence staining
Cellular subfractionation PC12 cells (2610 7 ) were detached from the plates, washed with ice-cold phosphate-buered saline and resuspended in 1 ml of mitochondrial homogenization buer containing 200 mM mannitol, 70 mM sucrose, 1 mM EGTA, 10 mM HEPES pH 7.5, 5 mM MgCl 2 , and 1 mM DTT, as well as the protease inhibitors aprotinin (0.15 U/ml), leupeptin (5 mg/ml) and phenylmethylsulfonyluoride (1 mM). The cells were incubated for 15 min on ice and then homogenized by about 200 strokes with a Dounce homogenizer. Samples were checked microscopically to ensure that most cells were lysed, and transferred to Eppendorf tubes and centrifuged at 500 g for 5 min at 48C to pellet the nuclei. The postnuclear supernatant was then centrifuged at 10 000 g for 10 min. The resulting pellet, representing heavy membranes, was resuspended in 1 ml of ice-cold homogenization buer and the supernatant was spun at 130 000 g for 30 min. The pellet, which was resuspended in 1 ml of ice-cold homogenization buer, represents the light membrane fraction, whereas the supernatant from this ®nal centrifugation represents the cytosolic fraction.
Total cell lysates PC12 cells were homogenized with homogenization buer (20 mM phosphate buer pH 7.4, 5 mM EDTA, 5 mM b-mercaptoethanol).
Immunoblotting Protein samples were separated by 12.5% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS ± PAGE) and electroblotted onto supported nitrocellulose. Equal amounts of protein (100 mg) from total cell lysates or equal portions of each subcellular fraction were loaded in each lane. Uniformity of sample loading was veri®ed by Ponceau staining of the blots. Each blot was blocked for 30 min in 10 mM Tris base, 150 mM NaCl containing 5% fat-free milk, then incubated for 16 h at 48C with the primary antibody. Rabbit anti-Bcl-x L/S S-18 (1 : 1000) or rabbit anti Bax P-19 (1 : 2000) (Santa Cruz Biotechnology, Santa Cruz, CA, USA) or mouse anti bovine cytochrome oxidase subunit IV (1 : 2000) (Molecular Probes, Eugene, OR, USA), or mouse anti cytochrome c (1 : 500) (Pharmingen, San Diego, CA, USA), or mouse anti porin (1 : 500) (CALBIOCHEM, La Jolla, CA, USA), or rabbit anti calenxin (1 : 500) (a gift from Ron Kopito from the Department of Biological Sciences, Stanford University, Stanford, CA, USA) was used as primary antibody. Goat anti rabbit (1 : 10 000) or goat anti mouse IgG peroxidase conjugate (1 : 5000) (Jackson Immunoresearch Laboratories Inc., PA, USA) were used as second antibody. The blots were developed using the Amersham Enhanced Chemiluminescence Kit (Amersham, Arlington Heights, IL, USA).
Immuno¯uorescence staining PC12 cells were grown in 6 well plates, 10 6 cells/well, on coverslips coated with collagen and transfected with 0.7 mg FLAG-Bcl-x S and 1.3 mg FLAGpcDNA3 constructs. Twenty-four hours after transfection, cells were incubated with 250 nM MitoTracker Red for 15 min at 378C to allow mitochondria staining. The following steps were carried out at room temperature: Cells were washed twice with buer B (2 mM CaCl 2 in TBS61), ®xed with 4% paraformaldehyde for 30 min, and then washed twice with buer B and permeabilized with 0.1% Triton for 10 min. After washing twice with buer B, cells were incubated with buer A (2 mM CaCl 2 , 2% BSA in TBS61) with normal goat IgG (200 mg/ml) (Jackson Immunoresearch Laboratories Inc., PA, USA) to block unspeci®c binding.
After washing with buer A, cells were incubated with buer A containing anti-FLAG M5 monoclonal antibody (10 mg/ml) (Sigma) for 1 h followed by three washes for 10 min with buer A and incubation for 30 min with buer A containing FITC-labeled goat anti mouse (2 mg/ml) (Jackson Laboratories Inc., PA, USA) which were preincubated for 1 h with total protein extracts powder from PC12 cells to block nonspeci®c binding. After three washes for 10 min with buer A, cells were air dried and mounted with mowiol (Hoechst AG, Germany) containing 29 nM n-propyl gallate (Sigma). Images were collected on a Zeiss LSM 410 confocal microscope equipped with a 25 mW Krypton-argon laser (488 and 568 maximum lines). A 406NA/1.2 Capochromat water immersion lens (Axiovert 135M, Zeiss) was used for all imaging.
Assay for SEAP activity SEAP activity was assayed as described previously (Berger et al., 1988) . Brie¯y, culture medium (200 ml) from transfected cells was collected and spun for 2 min at 10 000 g. The supernatant was incubated at 658C for 10 min and then aliquots (25 ml) from each treatment were incubated with 200 ml of SEAP buer (1 M diethanolamine, 0.5 mM MgCl 2 and 10 mM L-homo-arginine) at 378C until a yellow color developed. The plates were read on a Micro-ELISA reader at a wavelength of 405 nm.
